Published in J Virol on October 01, 2005
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe (2012) 3.23
Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci U S A (2008) 1.82
Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation. J Virol (2006) 1.58
Human cytomegalovirus UL38 protein blocks apoptosis. J Virol (2007) 1.55
Induction of apoptosis limits cytomegalovirus cross-species infection. EMBO J (2006) 1.43
Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores. Proc Natl Acad Sci U S A (2006) 1.35
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol (2006) 1.30
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol (2007) 1.13
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol (2009) 1.09
Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins. J Virol (2008) 1.09
Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein. J Virol (2009) 1.07
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol (2007) 1.07
Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins. J Virol (2006) 1.05
Quantitative proteomic analyses of human cytomegalovirus-induced restructuring of endoplasmic reticulum-mitochondrial contacts at late times of infection. Mol Cell Proteomics (2011) 1.02
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein. PLoS Pathog (2007) 0.99
Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products. J Virol (2006) 0.98
The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages. J Virol (2010) 0.97
Fowlpox virus encodes a Bcl-2 homologue that protects cells from apoptotic death through interaction with the proapoptotic protein Bak. J Virol (2007) 0.96
Access of viral proteins to mitochondria via mitochondria-associated membranes. Rev Med Virol (2009) 0.95
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev Biol (2006) 0.95
Human cytomegalovirus gene UL21a encodes a short-lived cytoplasmic protein and facilitates virus replication in fibroblasts. J Virol (2010) 0.93
Murine cytomegalovirus m38.5 protein inhibits Bax-mediated cell death. J Virol (2008) 0.92
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J Virol (2013) 0.91
Live or let die: manipulation of cellular suicide programs by murine cytomegalovirus. Med Microbiol Immunol (2012) 0.90
Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol (2005) 0.89
Trafficking of UL37 proteins into mitochondrion-associated membranes during permissive human cytomegalovirus infection. J Virol (2010) 0.88
Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV). Virology (2007) 0.86
Prevention of cellular suicide by cytomegaloviruses. Viruses (2012) 0.84
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection. J Virol (2010) 0.79
Regulation of the subcellular distribution of key cellular RNA-processing factors during permissive human cytomegalovirus infection. J Gen Virol (2010) 0.78
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis. Virology (2013) 0.77
Human Cytomegalovirus Infection Upregulates the Mitochondrial Transcription and Translation Machineries. MBio (2016) 0.76
Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner. Front Microbiol (2016) 0.75
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
Improved retroviral vectors for gene transfer and expression. Biotechniques (1989) 19.48
The biochemistry of apoptosis. Nature (2000) 18.91
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol (2005) 10.27
Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol (1998) 7.27
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Viral subversion of the immune system. Annu Rev Immunol (2000) 5.76
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J Virol (1999) 4.84
Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A (2003) 4.37
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A (2003) 4.21
Genetic content of wild-type human cytomegalovirus. J Gen Virol (2004) 3.58
Cloning of the complete human cytomegalovirus genome in cosmids. Gene (1982) 3.55
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol (2001) 3.50
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J Virol (1997) 3.16
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Two distinct pathways leading to nuclear apoptosis. J Exp Med (2000) 2.84
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods (1997) 2.69
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol (2002) 2.48
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol (2002) 1.89
The fight of viruses against apoptosis. Curr Opin Genet Dev (1998) 1.88
Viral mechanisms of immune evasion. Trends Microbiol (2000) 1.85
Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc Natl Acad Sci U S A (2004) 1.85
Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene (2004) 1.63
p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol (1998) 1.57
An anti-apoptotic viral protein that recruits Bax to mitochondria. J Biol Chem (2004) 1.49
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood (2004) 1.44
The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene (2001) 1.42
Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ (2002) 1.42
Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J Neurochem (1994) 1.37
The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology (2001) 1.30
Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein. J Virol (2003) 1.28
Bak and Bax function to limit adenovirus replication through apoptosis induction. J Virol (2002) 1.24
Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene (2001) 1.24
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene (2001) 1.22
The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family. Oncogene (2003) 1.22
Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J Gen Virol (2004) 1.21
Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol (2001) 1.19
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol (2005) 1.16
The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ (2002) 1.15
Cell death suppression by cytomegaloviruses. Apoptosis (2005) 1.13
vMIA, a viral inhibitor of apoptosis targeting mitochondria. Biochimie (2002) 1.10
Regulation of apoptosis by the ubiquitin and proteasome pathway. J Cell Mol Med (2002) 1.09
CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis. J Biol Chem (2001) 1.05
Mitochondrion-targeted apoptosis regulators of viral origin. Biochem Biophys Res Commun (2003) 1.02
A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol (2004) 0.99
To live or die by the sword: the regulation of apoptosis by the proteasome. Dev Cell (2004) 0.96
Natural cellular inhibitors of caspases. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.94
A novel checkpoint in the Bcl-2-regulated apoptotic pathway revealed by murine cytomegalovirus infection of dendritic cells. J Cell Biol (2004) 0.92
Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation. Antivir Ther (2003) 0.90
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 7.70
RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature (2011) 6.03
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe (2012) 3.23
Activation of innate immunity is required for efficient nuclear reprogramming. Cell (2012) 2.99
Biosynthetic labeling of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of mRNA synthesis and decay. Nat Biotechnol (2005) 2.92
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 2.75
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem (2013) 2.24
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol (2007) 1.97
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol (2004) 1.94
Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem (2008) 1.78
Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol (2012) 1.71
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol (2008) 1.66
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation (2004) 1.62
Optimization of a reusable hollow-fiber ultrafilter for simultaneous concentration of enteric bacteria, protozoa, and viruses from water. Appl Environ Microbiol (2003) 1.58
Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy. Neuron (2004) 1.56
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation (2006) 1.46
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol (2003) 1.44
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol (2006) 1.30
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. J Immunol (2013) 1.28
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood (2003) 1.19
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol (2005) 1.16
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood (2005) 1.15
Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150. J Virol (2008) 1.15
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation (2006) 1.11
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol (2009) 1.09
Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab. Clin Lymphoma Myeloma (2006) 1.09
RNA analysis by biosynthetic tagging using 4-thiouracil and uracil phosphoribosyltransferase. Methods Mol Biol (2008) 1.09
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 1.07
Application of carbon nanotube technology for removal of contaminants in drinking water: a review. Sci Total Environ (2009) 1.07
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J Virol (2011) 1.05
Microfabricated differential mobility spectrometry with pyrolysis gas chromatography for chemical characterization of bacteria. Anal Chem (2004) 1.01
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
The need and challenges for development of an Epstein-Barr virus vaccine. Vaccine (2013) 0.98
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol (2004) 0.97
Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo. J Interferon Cytokine Res (2004) 0.96
The preparation of a plasmonically resonant VO2 thermochromic pigment. Nanotechnology (2009) 0.96
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev Biol (2006) 0.95
Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol (2006) 0.94
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol (2011) 0.92
Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells. J Virol (2007) 0.92
Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J Clin Microbiol (2007) 0.92
Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses. J Virol (2013) 0.92
Analysis of bacterial strains with pyrolysis-gas chromatography/differential mobility spectrometry. Analyst (2006) 0.91
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J Virol (2013) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One (2009) 0.90
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood (2002) 0.90
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation (2011) 0.89
Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation (2007) 0.89
Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol (2005) 0.89
Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol (2015) 0.88
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82
Analysis of bacteria by pyrolysis gas chromatography-differential mobility spectrometry and isolation of chemical components with a dependence on growth temperature. Analyst (2007) 0.82
Antiviral T cell response triggers cytomegalovirus hepatitis in mice. J Virol (2012) 0.82
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. J Virol (2011) 0.80
Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction. J Virol (2014) 0.79
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus. Transplantation (2008) 0.79
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. J Heart Lung Transplant (2007) 0.78
Adsorption of Bacillus subtilis on single-walled carbon nanotube aggregates, activated carbon and NanoCeram. Water Res (2008) 0.77
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis. Virology (2013) 0.77
Cytomegalovirus and heart transplant atherosclerosis: a likely guilt hidden by weak proofs. Transplantation (2004) 0.75
Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Clin Infect Dis (2008) 0.75
Mechanisms modulating immune clearance during human cytomegalovirus latency. Proc Natl Acad Sci U S A (2012) 0.75
Adsorption kinetics of Escherichia coli and Staphylococcus aureus on single-walled carbon nanotube aggregates. Water Sci Technol (2008) 0.75
Extending the applicability of the four-flux radiative transfer method. Appl Opt (2017) 0.75
Residual toxicity after biodegradation: interactions among benzene, toluene, and chloroform. Ecotoxicol Environ Saf (2004) 0.75
The influence of redox potential on the degradation of halogenated methanes. Environ Toxicol Chem (2002) 0.75
The development of point-of-use water filters as sampling devices in bioforensics: extent of microbial sorption and elution. J Environ Monit (2008) 0.75
Natural antisense transcripts of UL123 packaged in human cytomegalovirus virions. Arch Virol (2013) 0.75
Directional and angle-resolved optical scattering of high-performance translucent polymer sheets for energy-efficient lighting and skylights. Appl Opt (2005) 0.75
Enzymatic Pre-treatment of Wastewater to Minimize Recovery by Reverse Transcriptase PCR of RNA from Inactive Bacteriophages. Curr Microbiol (2015) 0.75
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome]. G Ital Cardiol (Rome) (2007) 0.75